Navigation Links
Microdetermination of Phosphorus Using the SpectraMax Plus Microplate Spectrophotometer: Choice of Microplate, Cuvette, or Test Tube Assay Formats (MaxLine Application Note #24)

the original undiluted sample.

Step 3 Prepare the samples as recommended in the package insert (e.g. diluting urine samples with water, or trichloroacetate precipitation of serum samples to remove protein). The diluted samples should contain 1 - 25 g Pi/mL. Pipet 2.5 mL of each into 12 x 75 mm glass tubes.Step 4 Add 0.5 mL acid molybdate solution and 0.125 mL Fiske & Subbarow solution to each sample and standard. Mix briefly with a vortex mixer. If using the microplate method, accurately transfer 250 L of each reaction mixture into the preassigned wells of the microplate.

Step 5 Incubate 10 minutes at room temperature. If using test tubes, read the absorbance of each tube in the cuvette port of the SPECTRAmax PLUS microplate spectrophotometer. For the reference reading, use the 0 standard. If desired, the samples can be transferred into cuvettes before reading. If using a microplate, place it in the drawer of the SPECTRA-max PLUS, then read the plate.


SIGMA KIT RESULTS
Figure 3 compares standard curves obtained using the same solutions, but read in 12 x 75 glass tubes and in a microplate. Both curves have excellent linearity from 1 mg/dL to 25 mg/dL based on the concentration of the original samples before dilution. (The actual concentration range of the diluted standards before addition of reagent is 125 g/mL.) The microplate standard curve is approximately 30% lower than the tube curve, reflecting the correspondingly shorter pathlength through the 250 L samples in the wells.


CHEN et al MATERIALS
1. SPECTRAmax PLUS microplate spectrophotometer system

2. Test tubes (12 x 75 mm)

3. Transparent microplates (e.g. Polystyrene) with lids

4. 1 cm cuvettes (if desired)

5. Samples (200-300 mL each, containing 0.1 to 5.0 g Pi/mL)

6. Pipettor and tips

7. 37 C in
'"/>

Source:


Page: All 1 2 3 4 5 6 7

Related biology technology :

1. Low Abundance cDNA Cloned Using Stratagenes Human Universal cDNA Library
2. Oil-Free PCR Using the Hot Top Assembly
3. Functional Cloning Using ViraPort Retroviral cDNA Expression Libraries
4. Signal Transduction Reporting Systems Using Cis-Acting Enhancer Elements
5. Using XL1-Red Mutator Strain to Generate Esterase Variants
6. Detect Released Oligosaccharides Using the Eagle Eye II Still Video Imaging System
7. Comparison of Growth Techniques and Media for the Purpose of Plasmid Isolation from E. coli Using the Eppendorf Perfectprep Plasmid Mini Kit
8. Genomic DNA Extraction from Buccal Swabs Using the Perfect gDNA Blood Mini Kit
9. Genomic DNA Extraction from Buffy Coat Using the Perfect gDNA Blood Mini Kit
10. Isolation of Genomic DNA from Saliva Using the Perfect gDNA Blood Mini Kit
11. Protocol for RNA Isolation Using TRIzol Reagent with Phase Lock Gel-Heavy

Post Your Comments:
(Date:11/5/2009)...Nov. 5 Transgenomic, Inc...cial results for the quarter ended September 30, 2... in the tables that follow. ,, Third Quarter 2...,000 or $0.01 per share for the third quarter of 2... per share for the third quarter of 2008. ,, N...
(Date:11/5/2009)...f., Nov. 5 WaferGen Bios... developer of state-of-the-art genetic analysis sy...D. has joined the company,s Scientific Advisory Bo... commercializing novel molecular diagnostics for c... development of computational biology systems for ...
(Date:11/5/2009)... Brooke Sanders brings a new look to Pro Rep...ovember 5, 2009 -- Professional Reprographics, Ora...ompany is pleased to present Brooke Sanders to the...cs/PR specialist. The addition of Brooke to the co...ithin Professional Reprographics., , ,Brooke bring...
(Date:11/4/2009)...KVILLE, Md., Nov. 4 Zyngenia, Inc.... on next-generation antibody drug development, tod...ries A funding from New Enterprise Associates (NEA...s. The capital will be used to create novel, multi... or more biological targets with a single agent. T...
Breaking Biology Technology:Transgenomic, Inc. Reports Third Quarter 2009 Results 2Transgenomic, Inc. Reports Third Quarter 2009 Results 3Transgenomic, Inc. Reports Third Quarter 2009 Results 4Transgenomic, Inc. Reports Third Quarter 2009 Results 5Transgenomic, Inc. Reports Third Quarter 2009 Results 6Transgenomic, Inc. Reports Third Quarter 2009 Results 7WaferGen Names Christopher Sears, Ph.D., Architect of High-Value Molecular Diagnostics and Computational Biology Platforms, to Company's Scientific Advisory Board 2WaferGen Names Christopher Sears, Ph.D., Architect of High-Value Molecular Diagnostics and Computational Biology Platforms, to Company's Scientific Advisory Board 3WaferGen Names Christopher Sears, Ph.D., Architect of High-Value Molecular Diagnostics and Computational Biology Platforms, to Company's Scientific Advisory Board 4Zyngenia, Inc. Raises $10 Million in Series A Funding 2Zyngenia, Inc. Raises $10 Million in Series A Funding 3Zyngenia, Inc. Raises $10 Million in Series A Funding 4
...lix BioPharma Corp. (TSX, FSE: "HBP") today announ...scal 2009, ended January 31, 2009. , , RECENT H...-F registration statement with the U.S. Securities... March 12, 2009 , , , , , , Helix...European Phase II pharmacokinetic study in human s...
... Protocol Driven Healthcare , Inc. (PDHI) now of...(HRA), the ConXus(R) Profile. The shorter format f...racy and reduces processing costs of paper assessm..., longer adult HRA, but joins PDHI,s suite of Con...students, children, and Spanish-speaking adults. ...
...nership Will Increase Productivity to Meet Growing... Indonesia (PRWEB) March 16, 2009 -- DuPont and ...oday announced an agreement that grants DuPont bus...ialize ICRR rice hybrids in Asia. , , , , ,Rice is... of the world,s population. The growing populatio...
Other Biology Technology:Helix BioPharma Announces Q2 2009 Financial Results 2Helix BioPharma Announces Q2 2009 Financial Results 3Helix BioPharma Announces Q2 2009 Financial Results 4Helix BioPharma Announces Q2 2009 Financial Results 5Helix BioPharma Announces Q2 2009 Financial Results 6Helix BioPharma Announces Q2 2009 Financial Results 7Helix BioPharma Announces Q2 2009 Financial Results 8Helix BioPharma Announces Q2 2009 Financial Results 9Helix BioPharma Announces Q2 2009 Financial Results 10Helix BioPharma Announces Q2 2009 Financial Results 11Helix BioPharma Announces Q2 2009 Financial Results 12PDHI Launches Short Form of Its ConXus Profile Health Assessment 2DuPont Partners with Indonesian Center for Rice Research to Advance Hybrid Rice 2DuPont Partners with Indonesian Center for Rice Research to Advance Hybrid Rice 3
(Date:11/5/2009)...ty have developed synthetic molecules capable of e...-infected cells, as well as to prostate cancer cel...al of the American Chemical Society , could lead t... , The molecules called "antibody-recruiting m...iting molecule targeting prostate cancer" (ARM-P) ...
(Date:11/4/2009)...g Beach and Riverside are responsible for a signif...and the true impact of air pollution and ship emis...d, according to researchers at the University of S...pears in an online edition of the American Journa...f all childhood asthma cases in Long Beach and six...
(Date:11/4/2009)...eived more than $10 million in research grants fro...mulus program, bringing thetotal amount of stimulu...n. Thirty-three projects achieved stimulus fundin... , "The university has thoughtfully undertaken a... excellence to federal agency priorities. Through...
Breaking Biology News(10 mins):New synthetic molecules trigger immune response to HIV and prostate cancer 2USC study finds big air pollution impacts on local communities 2OU achieves $10 million in stimulus grants for 33 projects on the Norman campus 2OU achieves $10 million in stimulus grants for 33 projects on the Norman campus 3Zimmer Holdings to Present at Upcoming Investor Conferences 55934 1DIA Conference to Explore The Science and Scope of Personalized Medicine 55930 1DIA Conference to Explore The Science and Scope of Personalized Medicine 55930 2U S Labor Department announces dates for 4th annual Drug Free Work Week 55926 1U S Labor Department announces dates for 4th annual Drug Free Work Week 55926 2
...nced Identification Systems/Commerc... 28 /PRNewswire-FirstCall/-- Atmel (Nasdaq:,ATML),...ns, announced today,that Kerry Maletsky, Business ...nt "Secure Biometric Co-processor: Solving the Net...on Systems/Commercial Biometrics,Conference in Was...
...MEA spurs IdentiPHI,s company ...tiPHI, Inc., an innovative,leader in enterprise se...sion with the opening of an office in Paris to add...identity and authentication (access,management) pr...ope will enable us to more closely serve our,growi...
...cans are an increasingly used X-ray-based tool for...r organ or tissue. The value of CT scanning to dia...undisputed. But are these scans being used too fre... health consequences of having too many CT scans o... 2007 article in The New England Journal of Medici...
Other Biology News:Atmel's Biometric Co-processor Solution Featured at AIS/CBX 2IdentiPHI Opens Paris Office to Boost European Sales and Support 2Columbia researchers: Growth of CT scan use may lead to significant public health problem 2Columbia researchers: Growth of CT scan use may lead to significant public health problem 3
Mouse Anti-IFN-alpha2 Monoclonal Antibody, Fluorescein isothiocyanate (FITC) Conjugated, Clone 225.C from eBioscience
Mouse Anti-alpha Sodium Potassium ATPase Monoclonal Antibody, Unconjugated, Clone M7-PB-E9 from Abcam
Rabbit Anti-Human SP2 Polyclonal Antibody, Unconjugated from Atlas Antibodies
Rabbit Anti-Asparagine synthetase Monoclonal Antibody, Unconjugated, Clone EP282Y from Abcam
Biology Products: